News archive for Centre for Cancer Biomarkers CCBIO
CCBIO initiated its research school – CCBIO Research School for Cancer Studies (RSCS) – very early on, and the RSCS has since the startup in 2014 undergone a steady progress and expansion of the course portfolio. Now that CCBIO’s parent department the Department of Clinical Medicine has been assigned an FKB center (Centre for Clinical Treatment Research) – Neuro-SysMed – CCBIO is happy to be able... Read more
CCBIO’s PhD course CCBIO905 Methods in Cancer Biomarker Research was for the first time run on a digital platform October 27-29, 2020. The course was well attended, 80 participants followed selected lectures for non-ECTS participation, and 34 students completed the course with ECTS credits. The participants signed in from 15 different universities and 8 different countries with the majority of... Read more
In collaboration with the Vascular Biology Program (VBP), Boston Children’s Hospital, CCBIO recently completed the second CCBIO INTPART long course CCBIO907. This year, the course was given in digital format, and it was well visited by local students and researchers, participants from other institutions all over Norway, and also from Finland, Sweden and Denmark, in addition to some from other... Read more
CCBIO Postdoc Katrin Kleinmanns, together with CCBIO PhD Katharina Bischoff and Researcher Vibeke Fosse, recently published 2 articles in EBioMedicine. Their work describing CD24-targeted near-infrared (NIR) fluorescence imaging in patient-derived xenograft (PDX) models of high-grade serous ovarian carcinoma (HGSOC), confirms an improvement of cytoreduction of ovarian cancer in PDX orthotopic... Read more
The pandemic situation and lockdown of campus has forced CCBIO to think new in order to fulfill the goals for the CCBIO Research School for Cancer Studies. On fairly short notice, the 2 planned spring courses were rescheduled to new dates and organized through digital platforms. Despite of limited time to get the word out, registration for both courses soon had to be closed, due to great interest... Read more
The CCBIO International Faculty was established to support the Centre through active collaborations and strategic advice. In addition to the 13 already affiliated members, we have now recruited a new member, Marta Bertolaso from Rome, Italy, and have the pleasure of presenting her and her unique contribution to CCBIO.
CCBIO applied for and recently received continued support from the Research Council of Norway (RCN) and the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (DIKU) for phase 2 of the INTPART project: “Bergen-Harvard Cancer Studies phase 2: Continued Partnership for Responsible Education, Research and Innovation Excellence.”
CCBIO operates within the health services in addition to the Faculty of Medicine at the UiB and is subject to the guidelines issued by both institutions (see below links). As a consequence, we are reducing our activities accordingly. Please check the calendar for details. Notably, the CCBIO Annual Symposium and the Satellite Symposium have been cancelled.
CCBIO recently completed its CCBIO903 course Cancer Research: Ethical, Economic and Social Aspects, including a CCBIO Special Seminar, titled “Cancer in the news”. The course is quite unique on a global basis, and recruited participants with a great variety of backgrounds and of geographical locations, such as Bergen (CCBIO), Oslo (Oslo University Hospital, Institute for Cancer Research), London... Read more
Professor Hani Gabra was recently appointed Chief Medical Officer at BerGenBio, based in Oxford UK. Professor Gabra has been part of CCBIO's network of international affiliated researchers since 2016, and considers his affiliation to CCBIO both an advantage and a prerequisite for his role as CMO for BerGenBio. He also finds there are clear opportunities for increased interaction between BerGenBio... Read more
Since CCBIO was established five years ago, 17 students in the Medical Student Research Program have been affiliated to the center's research groups, and several have proceeded to a PhD degree. The students in the program are genuinely interested and dedicated, but also lacking research experience and in need of close follow-up and mentoring. Nevertheless, CCBIO has very good experiences in... Read more
In 2016 CCBIO’s Associate Investigator Professor Daniela Elena Costea received 3 million NOK in funding from the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (https://diku.no/en) for a 3 year collaboration project for education and research in oral pathology and oral cancer between Norway, Moldova, Belarus and Armenia. Due to its achievements, the... Read more
CCBIO Associate Researcher Agnete S.T. Engelsen has just completed a one-year certificate program, with distinction, at Harvard Medical School (HMS), the High-Impact Cancer Research (HICR): Cancer, Biology and Therapeutics Program. Engelsen was the first attendee from Norway in this diverse group of highly motivated new and seasoned researchers from 42 countries, all around the world.
CCBIO hosted the 4th Annual Scandinavian Seminar on Translational Pathology at Solstrand Hotel, Os (Bergen), with 78 dedicated participants from Norway, Sweden and Finland.
October 15th, Professor Bruce R. Zetter from Harvard Medical School and Boston Children’s Hospital was appointed as Honorary Doctor at the University of Bergen, Faculty of Medicine. The day before, October 14th, he gave his honorary doctor lecture, on the topic "RNA as a tool for cancer therapy".
Det medisinske fakultets nye æresdoktor Bruce R. Zetter sier at utnevnelsen vil føre til et enda sterkere bånd mellom Harvard Medical School og Universitetet i Bergen.
Iceland’s dramatic landscape served as backdrop for generating ideas and action plans for new collaborations between the University of Bergen/CCBIO and Harvard Medical School/Vascular Biology Program in a meeting August 29th to September 3rd.
Pages
- December 2023 (5)
- October 2023 (1)
- June 2023 (2)
- May 2023 (1)
- April 2023 (3)
- February 2023 (1)
- January 2023 (1)
- December 2022 (3)
- November 2022 (2)
- October 2022 (3)
- September 2022 (2)
- June 2022 (1)
- May 2022 (2)
- April 2022 (1)
- November 2021 (3)
- October 2021 (2)
- September 2021 (1)
- June 2021 (1)
- May 2021 (1)
- March 2021 (1)
- December 2020 (1)
- October 2020 (1)
- June 2020 (2)
- April 2020 (2)
- March 2020 (1)
- January 2020 (1)
- December 2019 (3)
- November 2019 (3)
- October 2019 (2)
- September 2019 (4)
- June 2019 (1)
- May 2019 (4)
- April 2019 (1)
- February 2019 (3)
- January 2019 (1)
- December 2018 (4)
- November 2018 (1)
- October 2018 (2)
- September 2018 (3)
- June 2018 (3)
- May 2018 (3)
- April 2018 (2)
- March 2018 (1)
- February 2018 (1)
- December 2017 (2)
- November 2017 (7)
- October 2017 (1)
- September 2017 (2)
- August 2017 (2)
- June 2017 (5)
- May 2017 (1)
- April 2017 (5)
- March 2017 (3)
- February 2017 (1)
- January 2017 (3)
- December 2016 (3)
- November 2016 (3)
- October 2016 (3)
- September 2016 (5)
- June 2016 (1)
- May 2016 (1)
- April 2016 (2)
- March 2016 (1)
- February 2016 (1)
- January 2016 (1)
- October 2015 (4)
- September 2015 (3)
- August 2015 (3)
- July 2015 (1)
- June 2015 (4)
- May 2015 (2)
- April 2015 (2)
- February 2015 (4)
- January 2015 (1)
- December 2014 (2)
- November 2014 (1)
- October 2014 (3)
- September 2014 (3)
- August 2014 (1)
- June 2014 (3)
- April 2014 (2)
- February 2014 (1)